Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Goto

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Annals of Hematology|November 20, 2020
High lymphocyte counts before antithymocyte globulin administration predict acute graft-versus-host diseaseSouichi Shiratori, Hiroyuki Ohigashi, Takahide Ara, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 17, 2017
Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantationNaohiro Miyashita, Tomoyuki Endo, Masahiro Onozawa, et al.
International Journal of Hematology|January 21, 2012
A fatal case of cytomegalovirus ventriculoencephalitis in a mycosis fungoides patient who received multiple umbilical cord blood cell transplantationsToshihiro Matsukawa, Hideki Goto, Kenta Takahashi, et al.
Annals of Hematology|February 2, 2020
Reduced dose of MTX for GVHD prophylaxis promotes engraftment and decreases non-relapse mortality in umbilical cord blood transplantationSouichi Shiratori, Hiroyuki Ohigashi, Shuichiro Takahashi, et al.
Antiviral Therapy|September 16, 2022
Antiretroviral therapy achieved metabolic complete remission of hepatic AIDS related Epstein-Barr virus-associated smooth muscle tumorTakahide Ara, Tomoyuki Endo, Hideki Goto, et al.
International Journal of Hematology|September 15, 2022
Zandelisib (ME-401) in Japanese patients with relapsed or refractory indolent non-Hodgkin's lymphoma: an open-label, multicenter, dose-escalation phase 1 studyHideki Goto, Koji Izutsu, Daisuke Ennishi, et al.
International Journal of Clinical Oncology|December 9, 2024
Efficacy and safety of mosunetuzumab monotherapy for Japanese patients with relapsed/refractory follicular lymphoma: FLMOON-1Hideki Goto, Takahiro Kumode, Yuko Mishima, et al.
Scientific Reports|December 15, 2015
RNAi mediated inhibition of viroid infection in transgenic plants expressing viroid-specific small RNAs derived from various functional domainsCharith Raj Adkar-Purushothama, Atsushi Kasai, Kohei Sugawara, et al.
Leukemia|January 7, 2026
Advances in the treatment and prognosis of aggressive NK-cell leukemia: results from the ANKL22 studyAyumi Fujimoto, Takeshi Maeda, Noriko Doki, et al.
International Journal of Hematology|November 20, 2022
Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trialNoriko Fukuhara, Koji Kato, Hideki Goto, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Annals of Hematology|November 20, 2020
High lymphocyte counts before antithymocyte globulin administration predict acute graft-versus-host diseaseSouichi Shiratori, Hiroyuki Ohigashi, Takahide Ara, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 17, 2017
Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantationNaohiro Miyashita, Tomoyuki Endo, Masahiro Onozawa, et al.
International Journal of Hematology|January 21, 2012
A fatal case of cytomegalovirus ventriculoencephalitis in a mycosis fungoides patient who received multiple umbilical cord blood cell transplantationsToshihiro Matsukawa, Hideki Goto, Kenta Takahashi, et al.
Annals of Hematology|February 2, 2020
Reduced dose of MTX for GVHD prophylaxis promotes engraftment and decreases non-relapse mortality in umbilical cord blood transplantationSouichi Shiratori, Hiroyuki Ohigashi, Shuichiro Takahashi, et al.
Antiviral Therapy|September 16, 2022
Antiretroviral therapy achieved metabolic complete remission of hepatic AIDS related Epstein-Barr virus-associated smooth muscle tumorTakahide Ara, Tomoyuki Endo, Hideki Goto, et al.
International Journal of Hematology|September 15, 2022
Zandelisib (ME-401) in Japanese patients with relapsed or refractory indolent non-Hodgkin's lymphoma: an open-label, multicenter, dose-escalation phase 1 studyHideki Goto, Koji Izutsu, Daisuke Ennishi, et al.
International Journal of Clinical Oncology|December 9, 2024
Efficacy and safety of mosunetuzumab monotherapy for Japanese patients with relapsed/refractory follicular lymphoma: FLMOON-1Hideki Goto, Takahiro Kumode, Yuko Mishima, et al.
Scientific Reports|December 15, 2015
RNAi mediated inhibition of viroid infection in transgenic plants expressing viroid-specific small RNAs derived from various functional domainsCharith Raj Adkar-Purushothama, Atsushi Kasai, Kohei Sugawara, et al.
Leukemia|January 7, 2026
Advances in the treatment and prognosis of aggressive NK-cell leukemia: results from the ANKL22 studyAyumi Fujimoto, Takeshi Maeda, Noriko Doki, et al.
International Journal of Hematology|November 20, 2022
Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trialNoriko Fukuhara, Koji Kato, Hideki Goto, et al.
Pageof 10